Sep 29, 2022 | False Claims Act, Government Investigations, Health Care Fraud
On September 26, 2022, the Department of Justice (DOJ) announced that pharmaceutical giant Biogen, Inc. agreed to pay $900 million to resolve allegations that it violated the False Claims Act (FCA) by paying prescribing physicians kickbacks in exchange for prescribing...
Sep 7, 2022 | Health Care Fraud
On September 2, the Department of Justice announced, “Bayer Corporation, an Indiana corporation and manufacturer of pharmaceutical products, and its related entities, Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare LLC and Bayer AG (collectively “Bayer”), have...
Aug 31, 2022 | Health Care Fraud
On August 25, 2022, the Eleventh Circuit upheld the convictions of a former Alabama physician, Patrick Ifediba, and his sister, Ngozi Justina Ozuligbo, who was a nurse who worked at a clinic run by her brother. They were charged and convicted of health care fraud,...
Aug 17, 2022 | Health Care, Health Care Fraud
In June 2022, the U.S. Supreme Court issued an opinion in Ruan v. United States that clarified the mens rea requirement for those who manufacture, distribute, or dispense drugs and are subsequently prosecuted under the Controlled Substances Act, specifically 21 U.S.C....
Aug 9, 2022 | Health Care, Health Care Fraud
The DOJ just announced the conviction of, Jaroslava Ruiz, for her role in a scheme that defrauded private health insurers of approximately $34.6 million. Ruiz, of Chapel Hill, was convicted of one count of conspiracy to commit health care fraud and wire fraud and 10...
Aug 3, 2022 | Health Care, Health Care Fraud
The U.S. Department of Health and Human Services issued a special fraud alert on July 20, 2022, relating to potential fraud concerns in the telehealth industry. Special fraud alerts are rare—this newest alert is only the fourth issued in the last decade. A special...
